Business
Tetra Bio-Pharma Inc. Announces Listing of Warrants
Tetra Bio-Pharma Inc. Announces Listing of Warrants.
About this update from Tetra Bio-pharma Inc.
[{"type":"text","content":"\n\n\n\nTetra Bio-Pharma Inc. Announces Listing of Warrants\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTetra Bio-Pharma Inc. Announces Listing of Warrants\nCanada NewsWire\nORLEANS, ON, Feb. 20, 2020\n\n\n\nORLEANS, ON, Feb. 20, 2020 /CNW Telbec/ - Tetra Bio-Pharma Inc. (\"Tetra\" or the \"Corporation\") (TSXV: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that a total of 31,292,471 common share purchase warrants (the \"Warrants\") of the Corporation will be listed and posted for trading under the symbol TBP.WT.B on the TSX Venture Exchange effective on or about February 25, 2020.\nThe Warrants were issued in connection with the Corporation's bought deal prospectus offering of Units (the \"Units\") that closed on February 13, 2020 (the \"Offering\"). Each Unit consisted of one common share (a \"Common Share\") and one Warrant. Each Warrant entitles the holder thereof to purchase one Common Share at an exercise price equal to $0.75 at any time before February 13, 2023. The Warrants to be listed on the TSX Venture Exchange also include a total of 2,047,171 Warrants which were issued to Echelon Wealth Partners Inc. as compensation for their services as underwriter for the Offering, as described in the Corporation's final short form prospectus dated February 6, 2020.\nThe Warrants are governed by the terms of a Warrant Indenture dated February 13, 2020 between the Corporation and Computershare Trust Company of Canada as warrant agent, a copy of which is available under the Corporation's profile at www.sedar.com. For further details regarding the Warrants, please refer to the Warrant Indenture.\nAbout Tetra Bio-Pharma:\nTetra Bio-Pharma (TSX-V:TBP) (OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced ...